What's Happening?
Ruminant BioTech, a New Zealand-based startup, has initiated a CAD$7.6 million ($5.6 million) research program in Canada to validate its methane reduction technology for pasture-based cattle. The program, supported by a CAD$2.8 million grant from Alberta's
government and additional industry funding, aims to commercialize a slow-release bolus that delivers a methane-inhibiting compound to cattle. This technology is designed to reduce methane emissions by 75% over three months with a single dose. The initiative will serve as a launchpad for global expansion, with plans to extend into the US, Brazil, and the EU.
Why It's Important?
Methane is a potent greenhouse gas, and reducing emissions from livestock is crucial for addressing climate change. Ruminant BioTech's technology offers a practical solution for pasture-raised cattle, which are challenging to manage with traditional feed additives. By providing a long-lasting and cost-effective method to reduce emissions, this initiative supports global efforts to meet climate targets. The program's success could influence agricultural practices worldwide, promoting sustainable livestock management and contributing to the reduction of global methane emissions.
What's Next?
Ruminant BioTech plans to establish a North American base in Calgary and begin the project in August. The company aims to secure regulatory approval in New Zealand by early 2026 and expand its production capacity. By 2035, the goal is to treat 100 million cows globally with this technology. The success of this program could lead to broader adoption of methane reduction strategies in agriculture, potentially influencing policy and market dynamics in the livestock industry.
